https://www.selleckchem.com/pr....oducts/tlr2-in-c29.h
However, current cancer immunotherapy has some limitations. ICIs fail to control tumors in a considerable proportion of cancer patients and CAR-T cell therapy does not effectively control solid tumors. To overcome these limitations, further research and development are required. In the current issue of BMB Reports, seven review articles in the field of cancer immunotherapy were published. [BMB Reports 2021; 54(1) 1-1]. The COVID-19 pandemic caused drastic changes in healthcare and severe social restrictions. Healthcare workers (HCWs
Like
Comment
Share
